To hear about similar clinical trials, please enter your email below
Trial Title:
Anxiety & Depression in Thyroid Cancer Patients
NCT ID:
NCT06269731
Condition:
Thyroid Cancer
Conditions: Official terms:
Thyroid Neoplasms
Thyroid Diseases
Depression
Conditions: Keywords:
depression
anxiety
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Cross-Sectional
Intervention:
Intervention type:
Behavioral
Intervention name:
Hamilton depression Rating Scale
Description:
also known as the Ham-D is the most widely used clinician-administered depression
assessment scale. The original version contains 17 items (HDRS17) pertaining to symptoms
of depression experienced over the past week. Although the scale was designed for
completion after an unstructured clinical interview, The scale has been translated into a
number of languages including French, German, Italian, Thai , Turkish and Arabic version
by Mostafa Lotfy.
Other name:
Hamilton Anxiety Rating Scale
Other name:
Quality of life Questionnaire
Other name:
Symptom Checklist-90-Revised
Summary:
1. To identify the prevalence of both anxiety and depression in thyroid cancer patients
2. To assess quality of life in thyroid cancer patients
Detailed description:
In recent years, increasing attention has been paid to mental health among cancer
patients.
Thyroid cancer is one of the most frequent endocrine neoplasia. It consists of 4 subtypes
of papillary thyroid cancer, follicular thyroid cancer, medullary thyroid cancer, and
anaplastic thyroid cancer.
Which is usually asymptomatic in the early stages, but symptoms such as neck pain,
hoarseness, and dysphagia may occur as the disease progresses. TC is diagnosed by
physical examination, analysis of thyroid hormone levels, imaging, and biopsy.
Anxiety and depression are the most common psychological problems in the treatment of
cancer patients and are related to the majority of medical diseases and physical
symptoms.
Studies have suggested that anxiety and depression are common in patients with thyroid
cancer.
Therefore, quality of life which includes psychological, social, and spiritual
well-being, has become an important consideration .
These findings highlight the importance of identifying thyroid cancer patients needs to
allow better and more adequate care and support.
Criteria for eligibility:
Study pop:
thyroid cancer patients
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
1. Age at or more than 18 years old
2. None of the patients had history of other psychiatric illness
3. Both sex
4. Accept to participate in the study
Exclusion Criteria:
1. Age less than 18 years old
2. Previous history of other psychiatric illness
3. substance abuser or dependence
4. Refuse to participate in the study
Gender:
All
Minimum age:
18 Years
Maximum age:
90 Years
Start date:
March 2024
Completion date:
March 2026
Lead sponsor:
Agency:
Assiut University
Agency class:
Other
Source:
Assiut University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06269731
